CCL Products (India) Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: May 31, 2025, 9:30 pm

Market Cap	11,806 Cr.
Current Price	884
High / Low	900/475
Stock P/E	38.0
Book Value	147
Dividend Yield	0.51 %
ROCE	13.1 %
ROE	17.0 %
Face Value	2.00
PEG Ratio	3.41

Stock P/E, Current Price, and Intrinsic Value Over Time

Stock P/E Current Price Intrinsic Value

View Share Price Target for CCL Products (India) Ltd

Competitors of CCL Products (India) Ltd

Stock Name ⇩	Market Cap ⇩	Current Price ⇩	High / Low ⇩	Stock P/E ⇩	Book Value ⇩	Dividend Yield ⇩	ROCE ⇩	ROE ⇩	Face Value ⇩
Goodricke Group Ltd	421 Cr.	195	357/159	28.6	125	0.00 %	5.29 %	5.76 %	10.0
Diana Tea Company Ltd	44.7 Cr.	29.8	53.8/23.5		43.0	0.00 %	1.22 %	6.88 %	5.00
Bengal Tea & Fabrics Ltd	141 Cr.	157	227/115		213	0.64 %	5.42 %	1.11 %	10.0
Bansisons Tea Industries Ltd	3.54 Cr.	5.60	8.90/3.80		9.27	0.00 %	0.50 %	1.02 %	10.0
B&A Ltd	143 Cr.	460	695/440	17.3	455	0.00 %	8.97 %	6.04 %	10.0
Industry Average	9,118.00 Cr	407.09		47.02	244.05	0.31%	7.72%	13.73%	7.00

All Competitor Stocks of CCL Products (India) Ltd

Quarterly Result

Metric	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025
Sales	376	509	507	535	520	655	608	664	727	773	738	758	836
Expenses	292	421	409	435	407	549	498	554	609	643	601	634	673
Operating Profit	84	89	98	101	113	106	110	111	118	130	137	124	163
OPM %	22%	17%	19%	19%	22%	16%	18%	17%	16%	17%	19%	16%	20%
Other Income	3	0	0	0	2	0	1	1	4	1	1	3	4
Interest	4	5	7	11	11	15	18	23	21	21	27	31	34
Depreciation	16	17	17	19	10	22	23	22	31	23	24	25	27
Profit before tax	68	67	73	71	95	69	70	67	70	87	87	72	106
Tax %	23%	21%	21%	-4%	10%	13%	13%	5%	7%	18%	15%	12%	4%
Net Profit	53	53	58	73	85	61	61	63	65	71	74	63	102
EPS in Rs	3.96	3.96	4.34	5.49	6.41	4.56	4.57	4.76	4.88	5.35	5.54	4.72	7.63

Last Updated: May 31, 2025, 9:33 am

Below is a detailed analysis of the quarterly data for CCL Products (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Sales, as of Mar 2025, the value is 836.00 Cr.. The value appears strong and on an upward trend. It has increased from 758.00 Cr. (Dec 2024) to 836.00 Cr., marking an increase of 78.00 Cr..
For Expenses, as of Mar 2025, the value is 673.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 634.00 Cr. (Dec 2024) to 673.00 Cr., marking an increase of 39.00 Cr..
For Operating Profit, as of Mar 2025, the value is 163.00 Cr.. The value appears strong and on an upward trend. It has increased from 124.00 Cr. (Dec 2024) to 163.00 Cr., marking an increase of 39.00 Cr..
For OPM %, as of Mar 2025, the value is 20.00%. The value appears strong and on an upward trend. It has increased from 16.00% (Dec 2024) to 20.00%, marking an increase of 4.00%.
For Other Income, as of Mar 2025, the value is 4.00 Cr.. The value appears strong and on an upward trend. It has increased from 3.00 Cr. (Dec 2024) to 4.00 Cr., marking an increase of 1.00 Cr..
For Interest, as of Mar 2025, the value is 34.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Dec 2024) to 34.00 Cr., marking an increase of 3.00 Cr..
For Depreciation, as of Mar 2025, the value is 27.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 25.00 Cr. (Dec 2024) to 27.00 Cr., marking an increase of 2.00 Cr..
For Profit before tax, as of Mar 2025, the value is 106.00 Cr.. The value appears strong and on an upward trend. It has increased from 72.00 Cr. (Dec 2024) to 106.00 Cr., marking an increase of 34.00 Cr..
For Tax %, as of Mar 2025, the value is 4.00%. The value appears to be improving (decreasing) as expected. It has decreased from 12.00% (Dec 2024) to 4.00%, marking a decrease of 8.00%.
For Net Profit, as of Mar 2025, the value is 102.00 Cr.. The value appears strong and on an upward trend. It has increased from 63.00 Cr. (Dec 2024) to 102.00 Cr., marking an increase of 39.00 Cr..
For EPS in Rs, as of Mar 2025, the value is 7.63. The value appears strong and on an upward trend. It has increased from 4.72 (Dec 2024) to 7.63, marking an increase of 2.91.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: May 15, 2025, 7:00 am

Metric	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Sales	717	881	932	976	1,138	1,081	1,139	1,242	1,462	2,071	2,654	3,106
Expenses	574	709	727	744	899	836	853	945	1,131	1,671	2,208	2,551
Operating Profit	143	171	205	232	239	245	286	298	331	400	445	555
OPM %	20%	19%	22%	24%	21%	23%	25%	24%	23%	19%	17%	18%
Other Income	3	3	1	1	5	3	4	3	4	3	6	8
Interest	17	14	11	11	8	8	18	17	16	34	78	113
Depreciation	29	27	28	33	34	32	47	49	57	64	98	98
Profit before tax	100	134	167	189	202	209	225	235	261	305	276	352
Tax %	35%	30%	27%	29%	27%	26%	26%	22%	22%	7%	9%	12%
Net Profit	64	94	122	135	148	155	166	182	204	284	250	310
EPS in Rs	4.84	7.06	9.18	10.12	11.14	11.64	12.47	13.70	15.36	21.35	18.73	23.24
Dividend Payout %	25%	21%	27%	25%	22%	30%	40%	29%	33%	21%	24%	21%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year	2014-2015	2015-2016	2016-2017	2017-2018	2018-2019	2019-2020	2020-2021	2021-2022	2022-2023	2023-2024	2024-2025
YoY Net Profit Growth (%)	46.88%	29.79%	10.66%	9.63%	4.73%	7.10%	9.64%	12.09%	39.22%	-11.97%	24.00%
Change in YoY Net Profit Growth (%)	0.00%	-17.09%	-19.13%	-1.03%	-4.90%	2.37%	2.54%	2.45%	27.13%	-51.19%	35.97%

CCL Products (India) Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.

Growth

Compounded Sales Growth
10 Years:	13%
5 Years:	22%
3 Years:	29%
TTM:	17%

Compounded Profit Growth
10 Years:	13%
5 Years:	13%
3 Years:	15%
TTM:	24%

Stock Price CAGR
10 Years:	17%
5 Years:	34%
3 Years:	35%
1 Year:	54%

Return on Equity
10 Years:	19%
5 Years:	18%
3 Years:	18%
Last Year:	17%

Last Updated: Unknown

Balance Sheet

Last Updated: May 13, 2025, 3:43 pm

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Equity Capital	27	27	27	27	27	27	27	27	27	27	27	27
Reserves	326	395	483	602	713	812	902	1,061	1,224	1,471	1,647	1,941
Borrowings	292	229	210	142	311	416	469	559	655	920	1,622	1,815
Other Liabilities	80	111	81	78	83	166	112	142	164	180	240	459
Total Liabilities	725	762	801	848	1,134	1,422	1,509	1,788	2,070	2,597	3,536	4,241
Fixed Assets	361	340	417	393	371	383	724	798	882	1,257	1,252	1,622
CWIP	39	53	0	0	226	424	100	149	160	54	501	450
Investments	2	2	2	2	1	1	1	0	0	0	0	0
Other Assets	324	367	382	453	535	613	684	841	1,028	1,286	1,783	2,169
Total Assets	725	762	801	848	1,134	1,422	1,509	1,788	2,070	2,597	3,536	4,241

Below is a detailed analysis of the balance sheet data for CCL Products (India) Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

For Equity Capital, as of Mar 2025, the value is 27.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 27.00 Cr..
For Reserves, as of Mar 2025, the value is 1,941.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,647.00 Cr. (Mar 2024) to 1,941.00 Cr., marking an increase of 294.00 Cr..
For Borrowings, as of Mar 2025, the value is 1,815.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 1,622.00 Cr. (Mar 2024) to 1,815.00 Cr., marking an increase of 193.00 Cr..
For Other Liabilities, as of Mar 2025, the value is 459.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 240.00 Cr. (Mar 2024) to 459.00 Cr., marking an increase of 219.00 Cr..
For Total Liabilities, as of Mar 2025, the value is 4,241.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 3,536.00 Cr. (Mar 2024) to 4,241.00 Cr., marking an increase of 705.00 Cr..
For Fixed Assets, as of Mar 2025, the value is 1,622.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,252.00 Cr. (Mar 2024) to 1,622.00 Cr., marking an increase of 370.00 Cr..
For CWIP, as of Mar 2025, the value is 450.00 Cr.. The value appears to be declining and may need further review. It has decreased from 501.00 Cr. (Mar 2024) to 450.00 Cr., marking a decrease of 51.00 Cr..
For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
For Other Assets, as of Mar 2025, the value is 2,169.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,783.00 Cr. (Mar 2024) to 2,169.00 Cr., marking an increase of 386.00 Cr..
For Total Assets, as of Mar 2025, the value is 4,241.00 Cr.. The value appears strong and on an upward trend. It has increased from 3,536.00 Cr. (Mar 2024) to 4,241.00 Cr., marking an increase of 705.00 Cr..

Notably, the Reserves (1,941.00 Cr.) exceed the Borrowings (1,815.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Reserves and Borrowings Chart

Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Cash from Operating Activity +	125	105	161	102	145	162	91	171	116	173	55	290
Cash from Investing Activity +	-58	-19	-87	-20	-247	-175	-88	-153	-192	-307	-527	-416
Cash from Financing Activity +	-42	-93	-82	-84	129	42	-37	64	9	164	559	53
Net Cash Flow	25	-8	-8	-2	27	29	-35	82	-67	30	86	-73

Free Cash Flow

Month	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Free Cash Flow	-149.00	-58.00	-5.00	90.00	-72.00	-171.00	-183.00	-261.00	-324.00	-520.00	444.00	554.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

Month	Mar 2013	Mar 2014	Mar 2015	Mar 2016	Mar 2017	Mar 2018	Mar 2019	Mar 2020	Mar 2021	Mar 2022	Mar 2023	Mar 2024
Debtor Days	49	54	47	50	61	58	79	86	88	80	78	68
Inventory Days	148	118	116	99	121	97	123	170	198	262	187	185
Days Payable	27	18	29	8	8	5	35	16	13	23	24	23
Cash Conversion Cycle	170	155	134	142	174	150	168	240	272	319	241	230
Working Capital Days	103	90	84	82	118	130	105	149	147	212	184	192
ROCE %	17%	19%	23%	26%	27%	23%	19%	18%	17%	16%	16%	12%

Financial Efficiency Indicators Chart

Share Holding Pattern

Month	Mar 2022	Jun 2022	Sep 2022	Dec 2022	Mar 2023	Jun 2023	Sep 2023	Dec 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024
Promoters	46.26%	46.26%	46.26%	46.26%	46.26%	46.26%	46.26%	46.26%	46.26%	46.09%	46.09%	46.09%
FIIs	8.19%	5.80%	7.56%	7.59%	7.75%	7.70%	7.75%	7.77%	8.12%	9.76%	10.17%	10.14%
DIIs	19.45%	22.34%	21.85%	21.81%	21.06%	21.05%	21.39%	21.44%	21.73%	20.57%	21.01%	21.06%
Public	26.10%	25.59%	24.32%	24.36%	24.95%	24.99%	24.61%	24.54%	23.89%	23.60%	22.73%	22.73%
No. of Shareholders	67,717	61,483	51,508	53,541	57,394	60,918	64,003	61,202	55,495	58,890	53,645	52,651

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund Name	No of Shares	AUM (%)	Amount Invested (Cr)	Previous Number of Shares	Previous Date	Percentage Change
SBI Magnum Global Fund	4,400,000	4.32	297	4,400,000	2025-04-22 15:56:59	0%
Canara Robeco ELSS Tax Saver Fund	1,041,623	0.79	70.31	1,041,623	2025-04-22 15:56:59	0%
Canara Robeco Small Cap Fund	487,897	0.27	32.93	487,897	2025-04-22 15:56:59	0%
SBI Magnum Comma Fund	425,000	4.34	28.69	425,000	2025-04-22 15:56:59	0%
LIC MF Flexi Cap Fund	194,778	1.18	13.15	194,778	2025-04-22 17:25:39	0%
Axis Capital Builder Fund - Series 4	223,401	0.92	12.68	223,401	2025-04-22 09:59:38	0%
LIC MF ELSS Tax Saver Fund	181,585	1.03	12.26	181,585	2025-04-22 15:56:59	0%
Canara Robeco Value Fund	180,000	0.94	12.15	180,000	2025-04-22 17:25:39	0%
LIC MF Multi Cap Fund	169,862	0.89	11.47	169,862	2025-04-22 16:12:48	0%
HSBC Small Cap Equity Fund - OLD	150,000	2.5	7.51	150,000	2025-04-22 15:56:59	0%

ROCE Trend

EPS Trend

Key Financial Ratios

Month	Mar 24	Mar 23	Mar 22	Mar 21	Mar 20
FaceValue	2.00	2.00	2.00	2.00	2.00
Basic EPS (Rs.)	18.80	20.21	15.36	13.70	12.47
Diluted EPS (Rs.)	18.76	20.21	15.36	13.70	12.47
Cash EPS (Rs.)	26.14	25.00	19.68	17.42	16.02
Book Value[Excl.RevalReserv]/Share (Rs.)	125.82	111.42	94.02	81.73	69.79
Book Value[Incl.RevalReserv]/Share (Rs.)	125.82	111.42	94.02	81.73	69.79
Revenue From Operations / Share (Rs.)	199.48	155.70	109.90	93.40	85.63
PBDIT / Share (Rs.)	33.95	30.30	25.19	22.64	21.83
PBIT / Share (Rs.)	26.61	25.51	20.87	18.92	18.29
PBT / Share (Rs.)	20.77	22.93	19.65	17.65	16.94
Net Profit / Share (Rs.)	18.80	20.21	15.36	13.70	12.47
NP After MI And SOA / Share (Rs.)	18.80	20.21	15.36	13.70	12.47
PBDIT Margin (%)	17.01	19.46	22.92	24.23	25.49
PBIT Margin (%)	13.33	16.38	18.99	20.26	21.35
PBT Margin (%)	10.40	14.72	17.87	18.89	19.77
Net Profit Margin (%)	9.42	12.98	13.97	14.66	14.56
NP After MI And SOA Margin (%)	9.42	12.98	13.97	14.66	14.56
Return on Networth / Equity (%)	14.94	18.14	16.33	16.76	17.87
Return on Capital Employeed (%)	15.67	19.27	19.28	19.07	19.72
Return On Assets (%)	7.07	10.35	9.87	10.19	10.99
Long Term Debt / Equity (X)	0.30	0.13	0.08	0.16	0.26
Total Debt / Equity (X)	0.96	0.61	0.44	0.43	0.42
Asset Turnover Ratio (%)	0.86	0.68	0.54	0.53	0.59
Current Ratio (X)	1.36	1.49	1.57	1.69	2.30
Quick Ratio (X)	0.74	0.79	0.74	1.01	1.36
Inventory Turnover Ratio (X)	2.38	1.57	1.35	1.35	2.15
Dividend Payout Ratio (NP) (%)	26.59	24.73	32.54	14.59	54.11
Dividend Payout Ratio (CP) (%)	19.12	19.99	25.40	11.48	42.14
Earning Retention Ratio (%)	73.41	75.27	67.46	85.41	45.89
Cash Earning Retention Ratio (%)	80.88	80.01	74.60	88.52	57.86
Interest Coverage Ratio (X)	5.81	11.72	20.49	17.76	16.17
Interest Coverage Ratio (Post Tax) (X)	4.22	8.82	13.49	11.75	10.24
Enterprise Value (Cr.)	9248.47	8386.00	5873.65	3469.07	2742.65
EV / Net Operating Revenue (X)	3.49	4.05	4.02	2.79	2.41
EV / EBITDA (X)	20.48	20.80	17.53	11.52	9.44
MarketCap / Net Operating Revenue (X)	2.94	3.65	3.67	2.51	2.10
Retention Ratios (%)	73.40	75.26	67.45	85.40	45.88
Price / BV (X)	4.66	5.10	4.29	2.86	2.57
Price / Net Operating Revenue (X)	2.94	3.65	3.67	2.51	2.10
EarningsYield	0.03	0.03	0.03	0.05	0.06

After reviewing the key financial ratios for CCL Products (India) Ltd, here is a detailed analysis based on the latest available data and recent trends:

For FaceValue, as of Mar 24, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 23) which recorded 2.00.
For Basic EPS (Rs.), as of Mar 24, the value is 18.80. This value is within the healthy range. It has decreased from 20.21 (Mar 23) to 18.80, marking a decrease of 1.41.
For Diluted EPS (Rs.), as of Mar 24, the value is 18.76. This value is within the healthy range. It has decreased from 20.21 (Mar 23) to 18.76, marking a decrease of 1.45.
For Cash EPS (Rs.), as of Mar 24, the value is 26.14. This value is within the healthy range. It has increased from 25.00 (Mar 23) to 26.14, marking an increase of 1.14.
For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 125.82. It has increased from 111.42 (Mar 23) to 125.82, marking an increase of 14.40.
For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 24, the value is 125.82. It has increased from 111.42 (Mar 23) to 125.82, marking an increase of 14.40.
For Revenue From Operations / Share (Rs.), as of Mar 24, the value is 199.48. It has increased from 155.70 (Mar 23) to 199.48, marking an increase of 43.78.
For PBDIT / Share (Rs.), as of Mar 24, the value is 33.95. This value is within the healthy range. It has increased from 30.30 (Mar 23) to 33.95, marking an increase of 3.65.
For PBIT / Share (Rs.), as of Mar 24, the value is 26.61. This value is within the healthy range. It has increased from 25.51 (Mar 23) to 26.61, marking an increase of 1.10.
For PBT / Share (Rs.), as of Mar 24, the value is 20.77. This value is within the healthy range. It has decreased from 22.93 (Mar 23) to 20.77, marking a decrease of 2.16.
For Net Profit / Share (Rs.), as of Mar 24, the value is 18.80. This value is within the healthy range. It has decreased from 20.21 (Mar 23) to 18.80, marking a decrease of 1.41.
For NP After MI And SOA / Share (Rs.), as of Mar 24, the value is 18.80. This value is within the healthy range. It has decreased from 20.21 (Mar 23) to 18.80, marking a decrease of 1.41.
For PBDIT Margin (%), as of Mar 24, the value is 17.01. This value is within the healthy range. It has decreased from 19.46 (Mar 23) to 17.01, marking a decrease of 2.45.
For PBIT Margin (%), as of Mar 24, the value is 13.33. This value is within the healthy range. It has decreased from 16.38 (Mar 23) to 13.33, marking a decrease of 3.05.
For PBT Margin (%), as of Mar 24, the value is 10.40. This value is within the healthy range. It has decreased from 14.72 (Mar 23) to 10.40, marking a decrease of 4.32.
For Net Profit Margin (%), as of Mar 24, the value is 9.42. This value is within the healthy range. It has decreased from 12.98 (Mar 23) to 9.42, marking a decrease of 3.56.
For NP After MI And SOA Margin (%), as of Mar 24, the value is 9.42. This value is within the healthy range. It has decreased from 12.98 (Mar 23) to 9.42, marking a decrease of 3.56.
For Return on Networth / Equity (%), as of Mar 24, the value is 14.94. This value is below the healthy minimum of 15. It has decreased from 18.14 (Mar 23) to 14.94, marking a decrease of 3.20.
For Return on Capital Employeed (%), as of Mar 24, the value is 15.67. This value is within the healthy range. It has decreased from 19.27 (Mar 23) to 15.67, marking a decrease of 3.60.
For Return On Assets (%), as of Mar 24, the value is 7.07. This value is within the healthy range. It has decreased from 10.35 (Mar 23) to 7.07, marking a decrease of 3.28.
For Long Term Debt / Equity (X), as of Mar 24, the value is 0.30. This value is within the healthy range. It has increased from 0.13 (Mar 23) to 0.30, marking an increase of 0.17.
For Total Debt / Equity (X), as of Mar 24, the value is 0.96. This value is within the healthy range. It has increased from 0.61 (Mar 23) to 0.96, marking an increase of 0.35.
For Asset Turnover Ratio (%), as of Mar 24, the value is 0.86. It has increased from 0.68 (Mar 23) to 0.86, marking an increase of 0.18.
For Current Ratio (X), as of Mar 24, the value is 1.36. This value is below the healthy minimum of 1.5. It has decreased from 1.49 (Mar 23) to 1.36, marking a decrease of 0.13.
For Quick Ratio (X), as of Mar 24, the value is 0.74. This value is below the healthy minimum of 1. It has decreased from 0.79 (Mar 23) to 0.74, marking a decrease of 0.05.
For Inventory Turnover Ratio (X), as of Mar 24, the value is 2.38. This value is below the healthy minimum of 4. It has increased from 1.57 (Mar 23) to 2.38, marking an increase of 0.81.
For Dividend Payout Ratio (NP) (%), as of Mar 24, the value is 26.59. This value is within the healthy range. It has increased from 24.73 (Mar 23) to 26.59, marking an increase of 1.86.
For Dividend Payout Ratio (CP) (%), as of Mar 24, the value is 19.12. This value is below the healthy minimum of 20. It has decreased from 19.99 (Mar 23) to 19.12, marking a decrease of 0.87.
For Earning Retention Ratio (%), as of Mar 24, the value is 73.41. This value exceeds the healthy maximum of 70. It has decreased from 75.27 (Mar 23) to 73.41, marking a decrease of 1.86.
For Cash Earning Retention Ratio (%), as of Mar 24, the value is 80.88. This value exceeds the healthy maximum of 70. It has increased from 80.01 (Mar 23) to 80.88, marking an increase of 0.87.
For Interest Coverage Ratio (X), as of Mar 24, the value is 5.81. This value is within the healthy range. It has decreased from 11.72 (Mar 23) to 5.81, marking a decrease of 5.91.
For Interest Coverage Ratio (Post Tax) (X), as of Mar 24, the value is 4.22. This value is within the healthy range. It has decreased from 8.82 (Mar 23) to 4.22, marking a decrease of 4.60.
For Enterprise Value (Cr.), as of Mar 24, the value is 9,248.47. It has increased from 8,386.00 (Mar 23) to 9,248.47, marking an increase of 862.47.
For EV / Net Operating Revenue (X), as of Mar 24, the value is 3.49. This value exceeds the healthy maximum of 3. It has decreased from 4.05 (Mar 23) to 3.49, marking a decrease of 0.56.
For EV / EBITDA (X), as of Mar 24, the value is 20.48. This value exceeds the healthy maximum of 15. It has decreased from 20.80 (Mar 23) to 20.48, marking a decrease of 0.32.
For MarketCap / Net Operating Revenue (X), as of Mar 24, the value is 2.94. This value is within the healthy range. It has decreased from 3.65 (Mar 23) to 2.94, marking a decrease of 0.71.
For Retention Ratios (%), as of Mar 24, the value is 73.40. This value exceeds the healthy maximum of 70. It has decreased from 75.26 (Mar 23) to 73.40, marking a decrease of 1.86.
For Price / BV (X), as of Mar 24, the value is 4.66. This value exceeds the healthy maximum of 3. It has decreased from 5.10 (Mar 23) to 4.66, marking a decrease of 0.44.
For Price / Net Operating Revenue (X), as of Mar 24, the value is 2.94. This value is within the healthy range. It has decreased from 3.65 (Mar 23) to 2.94, marking a decrease of 0.71.
For EarningsYield, as of Mar 24, the value is 0.03. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 23) which recorded 0.03.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of CCL Products (India) Ltd as of June 1, 2025 is: 763.57

Calculation basis:

Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of June 1, 2025, CCL Products (India) Ltd is Overvalued by 13.62% compared to the current share price 884.00

Intrinsic Value of CCL Products (India) Ltd as of June 1, 2025 is: 848.70

Calculation basis:

Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of June 1, 2025, CCL Products (India) Ltd is Overvalued by 3.99% compared to the current share price 884.00

Last 5 Year EPS CAGR: 11.15%

*Investments are subject to market risks

Strength and Weakness

Strength	Weakness
The stock has a high average ROCE of 19.42%, which is a positive sign. The company has higher reserves (964.75 cr) compared to borrowings (636.67 cr), indicating strong financial stability. The company has shown consistent growth in sales (293.17 cr) and profit (221.25 cr) over the years.	The stock has a high average Working Capital Days of 133.00, which may not be favorable. The stock has a high average Cash Conversion Cycle of 199.58, which may not be favorable.

Stock Analysis

Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in CCL Products (India) Ltd:
1. Net Profit Margin: 9.42%
  - Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
2. ROCE: 15.67% (Industry Average ROCE: 7.72%)
  - ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
3. ROE%: 14.94% (Industry Average ROE: 13.73%)
  - ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
4. Interest Coverage Ratio (Post Tax): 4.22
  - Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
5. Quick Ratio: 0.74
  - Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
6. Stock P/E: 38 (Industry average Stock P/E: 47.02)
  - Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
7. Total Debt / Equity: 0.96
  - Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
Stock Rating:

About the Company - Qualitative Analysis

CCL Products India Ltd. is a Public Limited Listed company incorporated on 22/03/1961 and has its registered office in the State of Andhra Pradesh, India. Company's Corporate Identification Number(CIN) is L15110AP1961PLC000874 and registration number is 000874. Currently Company is involved in the business activities of Coffee curing, roasting, grinding blending etc. and manufacturing of coffee products. Company's Total Operating Revenue is Rs. 1718.00 Cr. and Equity Capital is Rs. 26.71 Cr. for the Year ended 31/03/2025.

INDUSTRY	ADDRESS	CONTACT
Plantations - Tea & Coffee	Duggirala, Guntur District Andhra Pradesh 522330	info@continental.coffee http://www.cclproducts.com

Management
Name	Position Held
Mr. Challa Rajendra Prasad	Chairman & Executive Director
Mr. Challa Srishant	Managing Director
Mr. B Mohan Krishna	Executive Director
Ms. Challa Shantha Prasad	Non Executive Director
Mr. K K Sarma	Non Executive Director
Mr. Satyavada Venkata Ramachandra Rao	Non Executive Director
Mr. G V Krishna Rau	Ind. Non-Executive Director
Mr. K V Chowdary	Ind. Non-Executive Director
Mr. Durga Prasad Kode	Ind. Non-Executive Director
Mrs. Kulsoom Noor Saifullah	Ind. Non-Executive Director
Dr. Krishnanand Lanka	Ind. Non-Executive Director
Mr. Sudhakar Ambati	Ind. Non-Executive Director

FAQ

What is the intrinsic value of CCL Products (India) Ltd?

CCL Products (India) Ltd's intrinsic value (as of 31 May 2025) is ₹763.57 — 13.62% lower the current market price of 884.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's 11,806 Cr. market cap, FY2025-2026 high/low of ₹900/475, reserves of 1,941 Cr, and liabilities of 4,241 Cr.

What is the Market Cap of CCL Products (India) Ltd?

The Market Cap of CCL Products (India) Ltd is 11,806 Cr..

What is the current Stock Price of CCL Products (India) Ltd as on 31 May 2025?

The current stock price of CCL Products (India) Ltd as on 31 May 2025 is 884.

What is the High / Low of CCL Products (India) Ltd stocks in FY 2025-2026?

In FY 2025-2026, the High / Low of CCL Products (India) Ltd stocks is ₹900/475.

What is the Stock P/E of CCL Products (India) Ltd?

The Stock P/E of CCL Products (India) Ltd is 38.0.

What is the Book Value of CCL Products (India) Ltd?

The Book Value of CCL Products (India) Ltd is 147.

What is the Dividend Yield of CCL Products (India) Ltd?

The Dividend Yield of CCL Products (India) Ltd is 0.51 %.

What is the ROCE of CCL Products (India) Ltd?

The ROCE of CCL Products (India) Ltd is 13.1 %.

What is the ROE of CCL Products (India) Ltd?

The ROE of CCL Products (India) Ltd is 17.0 %.

What is the Face Value of CCL Products (India) Ltd?

The Face Value of CCL Products (India) Ltd is 2.00.